Moderna shares fell 3% Thursday afternoon, after reports that federal health officials are re-evaluating the company’s $590 million contract to help develop a bird-flu vaccine. Moderna was awarded the ...

Neil Vaccines are medicine which protect the human body by making it immune from a certain disease. Now, there’s been a sudden and important discovery – a breakthrough - in the development of a new ...

A new study from Memorial Sloan Kettering Cancer Center shows good results for patients with pancreatic cancer. They used a personalized mRNA vaccine, which offers new hope. This pancreatic cancer ...

The news was reported by Bloomberg late Wednesday, citing people familiar with the matter. In the final days of President Joe Biden's term, Moderna (MRNA) won the $590 million contract to use its mRNA ...

Moderna Inc.'s stock tumbled 4% Thursday, after a report that health officials are reviewing a contract the company won from the Biden administration to support its efforts to develop a bird-flu ...

Taiwanese scientists have discovered a new way to synthesize circular RNA (circRNA), which could be applied to vaccine ...

More than 2.7 million confirmed national cases of Covid-19 have been logged since our very first was announced on February 28 ...

The Trump administration confirmed it's reviewing whether to pull $590 million in funding that Moderna received in the final ...

US health officials are reevaluating a $590 million contract for bird flu shots that the Biden administration awarded to ...

Moderna (NASDAQ: MRNA) became a hot investment during the pandemic as its COVID vaccine made investors bullish on its future. One way Moderna has been trying to appease investors and reduce its losses ...

A new type of mRNA vaccine, added to standard cancer treatment, could help some patients with pancreatic cancer live longer.

U.S. health officials are reevaluating a $590 million contract that was awarded to Moderna for the development of its bird ...